Trillium Asset Management, LLC Astrazeneca PLC Transaction History

Trillium Asset Management, LLC

$4 Billion
Q3 2024

A detailed history of Trillium Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Trillium Asset Management, LLC holds 701,923 shares of AZN stock, worth $45.9 Million. This represents 1.37% of its overall portfolio holdings.

Number of Shares

701,923

Previous 713,243 1.59%

Holding current value

$45.9 Million

Previous $55.6 Million 1.68%

% of portfolio

1.37%

Previous 1.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$76.67 - $87.62 $867,904 - $991,858	-11,320 Reduced 1.59%	701,923 $54.7 Million
Q2 2024 Aug 07, 2024	SELL	$66.81 - $80.83 $1.8 Million - $2.18 Million	-26,952 Reduced 3.64%	713,243 $55.6 Million
Q1 2024 May 09, 2024	BUY	$61.03 - $69.57 $426,294 - $485,946	6,985 Added 0.95%	740,195 $50.1 Million
Q4 2023 Feb 08, 2024	SELL	$61.89 - $69.28 $1.17 Million - $1.31 Million	-18,893 Reduced 2.51%	733,210 $49.4 Million
Q3 2023 Nov 07, 2023	SELL	$64.85 - $71.7 $236,702 - $261,705	-3,650 Reduced 0.48%	752,103 $50.9 Million
Q2 2023 Aug 09, 2023	SELL	$69.91 - $75.81 $8.61 Million - $9.34 Million	-123,183 Reduced 14.02%	755,753 $54.1 Million
Q1 2023 May 08, 2023	BUY	$63.15 - $71.6 $2.53 Million - $2.87 Million	40,117 Added 4.78%	878,936 $61 Million
Q4 2022 Feb 07, 2023	BUY	$54.21 - $70.44 $1.06 Million - $1.38 Million	19,544 Added 2.39%	838,819 $56.9 Million
Q3 2022 Nov 09, 2022	BUY	$53.02 - $135.75 $2.08 Million - $5.33 Million	39,290 Added 5.04%	819,275 $44.9 Million
Q2 2022 Aug 08, 2022	BUY	$59.26 - $71.14 $4.47 Million - $5.37 Million	75,415 Added 10.7%	779,985 $51.5 Million
Q1 2022 May 04, 2022	BUY	$55.72 - $67.12 $2.44 Million - $2.94 Million	43,850 Added 6.64%	704,570 $46.7 Million
Q4 2021 Feb 08, 2022	BUY	$54.02 - $63.83 $1.39 Million - $1.64 Million	25,662 Added 4.04%	660,720 $38.5 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $803,953 - $879,631	14,470 Added 2.33%	635,058 $38.1 Million
Q2 2021 Aug 06, 2021	BUY	$48.42 - $60.18 $2.74 Million - $3.4 Million	56,494 Added 10.01%	620,588 $37.1 Million
Q1 2021 May 10, 2021	BUY	$47.16 - $54.44 $2.73 Million - $3.15 Million	57,856 Added 11.43%	564,094 $28 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $2.09 Million - $2.5 Million	43,112 Added 9.31%	506,238 $25.3 Million
Q3 2020 Nov 09, 2020	SELL	$53.07 - $61.1 $1.41 Million - $1.62 Million	-26,480 Reduced 5.41%	463,126 $25.4 Million
Q2 2020 Aug 06, 2020	BUY	$43.1 - $55.31 $2.32 Million - $2.98 Million	53,856 Added 12.36%	489,606 $25.9 Million
Q1 2020 May 07, 2020	BUY	$37.79 - $51.33 $9.99 Million - $13.6 Million	264,373 Added 154.26%	435,750 $19.5 Million
Q4 2019 Feb 10, 2020	BUY	$42.46 - $50.46 $433,856 - $515,600	10,218 Added 6.34%	171,377 $8.55 Million
Q3 2019 Nov 06, 2019	BUY	$40.12 - $45.47 $6.47 Million - $7.33 Million	161,159 New	161,159 $7.18 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trillium Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trillium Asset Management, LLC with notifications on news.

Account

Trillium Asset Management, LLC Astrazeneca PLC Transaction History